Literature DB >> 26662728

The 'Adapted ADAPTE': an approach to improve utilization of the ADAPTE guideline adaptation resource toolkit in the Alexandria Center for Evidence-Based Clinical Practice Guidelines.

Yasser Sami Amer1,2,3, Mahmoud Munir Elzalabany1,4, Tarek Ismael Omar1,4, Afaf Gaber Ibrahim1,5, Nabil Lotfy Dowidar1,6,7.   

Abstract

RATIONALE, AIMS AND
OBJECTIVES: The ADAPTE methodology for adaptation of guidelines has been used by many organizations to develop high-quality clinical practice guidelines. Although it is a valid alternative for de novo development of guidelines, it might demand more time and resources in some institutions. The present study demonstrates the proposed 'adapted ADAPTE' methodology to support more clarity, simplicity and practicality. It also aims at avoiding duplication within the process and reducing the resources and time allocated to the CPG adaptation projects.
METHODS: Clinical guidelines' adaptation in the Center for Evidence-Based Clinical Practice Guidelines at the Alexandria Faculty of Medicine and University Hospitals involves two stages: (1) cross-sectional or retrospective study to reveal the current practice and prescribing patterns concerning the selected health topic; (2) the 'adapted ADAPTE' methodology for CPGs adaptation that was based on the original ADAPTE Process.
RESULTS: The 'adapted ADAPTE' included three modified tools, three new tools based on the original ADAPTE framework and alternatives for four ADAPTE steps to enhance utilization. The finalized adapted CPGs included nine high priority topics for paediatrics and two topics for emergency medicine.
CONCLUSIONS: The ADAPTE methodology for guideline adaptation can be customized or 'adapted' to the local health care setting and resources. This proposal facilitates supports and improves the utilization and update of the ADAPTE process by CPG programmes or activities in health care organizations. This is of particular importance in health care systems in developing countries with limited resources in the Eastern Mediterranean region like Egypt.
© 2015 John Wiley & Sons, Ltd.

Keywords:  adaptation; clinical guidelines; experience; health care

Mesh:

Year:  2015        PMID: 26662728     DOI: 10.1111/jep.12479

Source DB:  PubMed          Journal:  J Eval Clin Pract        ISSN: 1356-1294            Impact factor:   2.431


  14 in total

Review 1.  A comparison of international clinical practice guidelines on adult chronic rhinosinusitis shows considerable variability of recommendations for diagnosis and treatment.

Authors:  N M Kaper; G J M G van der Heijden; S H Cuijpers; R J Stokroos; M C J Aarts
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-12-16       Impact factor: 2.503

2.  AGREEing on clinical practice guidelines for idiopathic steroid-sensitive nephrotic syndrome in children.

Authors:  Khalid Abdulaziz Alhasan; Reem Al Khalifah; Majed Aloufi; Weiam Almaiman; Muddathir Hamad; Naif Abdulmajeed; Abdullah Al Salloum; Jameela A Kari; Muneera AlJelaify; Rolan K Bassrawi; Turki Al Hussain; Adi Alherbish; Abdulhadi Al Talhi; Mohamad-Hani Temsah; Sidharth Kumar Sethi; Rupesh Raina; Reny Joseph; Yasser Sami Amer
Journal:  Syst Rev       Date:  2021-05-10

3.  Management of convulsive status epilepticus in children: an adapted clinical practice guideline for pediatricians in Saudi Arabia.

Authors:  Fahad A Bashiri; Muddathir H Hamad; Yasser S Amer; Manal M Abouelkheir; Sarar Mohamed; Amal Y Kentab; Mustafa A Salih; Mohammad N Al Nasser; Ayman A Al-Eyadhy; Mohammed A Al Othman; Tahani Al-Ahmadi; Shaikh M Iqbal; Ali M Somily; Hayfaa A Wahabi; Khalid J Hundallah; Ali H Alwadei; Raidah S Albaradie; Waleed A Al-Twaijri; Mohammed M Jan; Faisal Al-Otaibi; Abdulrahman M Alnemri; Lubna A Al-Ansary
Journal:  Neurosciences (Riyadh)       Date:  2017-04       Impact factor: 0.906

4.  The advantages and limitations of guideline adaptation frameworks.

Authors:  Zhicheng Wang; Susan L Norris; Lisa Bero
Journal:  Implement Sci       Date:  2018-05-29       Impact factor: 7.327

5.  Algorithm-based decision support for symptom self-management among adults with Cancer: results of usability testing.

Authors:  Mary E Cooley; Janet L Abrahm; Donna L Berry; Michael S Rabin; Ilana M Braun; Joanna Paladino; Manan M Nayak; David F Lobach
Journal:  BMC Med Inform Decis Mak       Date:  2018-05-29       Impact factor: 2.796

6.  Global variation of risk thresholds for initiating statins for primary prevention of cardiovascular disease: a benefit-harm balance modelling study.

Authors:  Henock G Yebyo; Sofia Zappacosta; Hélène E Aschmann; Sarah R Haile; Milo A Puhan
Journal:  BMC Cardiovasc Disord       Date:  2020-09-17       Impact factor: 2.298

7.  Appraisal of clinical practice guidelines for the management of attention deficit hyperactivity disorder (ADHD) using the AGREE II Instrument: A systematic review.

Authors:  Yasser Sami Amer; Haya Faisal Al-Joudi; Jeremy L Varnham; Fahad A Bashiri; Muddathir Hamad Hamad; Saleh M Al Salehi; Hadeel Fakhri Daghash; Turki Homod Albatti
Journal:  PLoS One       Date:  2019-07-05       Impact factor: 3.240

8.  Variations in processes for guideline adaptation: a qualitative study of World Health Organization staff experiences in implementing guidelines.

Authors:  Zhicheng Wang; Quinn Grundy; Lisa Parker; Lisa Bero
Journal:  BMC Public Health       Date:  2020-11-23       Impact factor: 3.295

9.  Current practices and challenges in adaptation of clinical guidelines: a qualitative study based on semistructured interviews.

Authors:  Yang Song; Monica Ballesteros; Jing Li; Laura Martínez García; Ena Niño de Guzmán; Robin W M Vernooij; Elie A Akl; Francoise Cluzeau; Pablo Alonso-Coello
Journal:  BMJ Open       Date:  2021-12-02       Impact factor: 2.692

10.  Quality assessment of evidence-based clinical practice guidelines for the management of pregnant women with sickle cell disease using the AGREE II instrument: a systematic review.

Authors:  Yasser S Amer; Yasser Sabr; Ghada M ElGohary; Amer M Altaki; Osamah T Khojah; Ahmed El-Malky; Musa F Alzahrani
Journal:  BMC Pregnancy Childbirth       Date:  2020-10-07       Impact factor: 3.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.